The Journal of Bone and Joint Surgery 78:967-8 (1996)
© 1996 The Journal of Bone and Joint Surgery, Inc.
Correspondence
Douglas Linville, M.D.,
Robert J. Fragen, M.D.,
S. David Stulberg, M.D.,
Richard Wixson, M.D.,
Silas Glisson, Ph.D. and
Eleanor Librojo, R.N.
TO THE EDITOR:
I read the article "Effect of Ketorolac Tromethamine on Bleeding and on Requirements for Analgesia after Total Knee Arthroplasty" (77-A: 9981002, July 1995), by Fragen et al., with great interest. I find it hopeful that excellent analgesia can be obtained with a non-opiate substance in order to limit side effects in an often elderly population at risk for complications. I am still concerned, however, about bleeding and wound complications in the total joint population. These very important complications, which may prove catastrophic, were not addressed in this study.
As we know from the literature regarding prophylactic therapy with low-dose warfarin and low-molecular-weight heparin, substantial bleeding episodes occur in as many as 5 per cent of treated patients2,4. In these reports, a major bleeding episode was defined as a decrease in hemoglobin of 0.002 gram per deciliter or more, the need for a transfusion of two units . . . [Full Text of this Article]

CiteULike Connotea Del.icio.us Technorati What's this?
|